{
  "ticker": "AGN",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971945",
  "id": "02971945",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250723",
  "time": "1548",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250723/pdf/06m26zlm7r3kwl.pdf",
  "summary": "- **Substantial Holder Change**: Insignia Financial Ltd (via subsidiaries) ceased to be a substantial holder in Argenica Therapeutics (AGN) as of 16-Jul-2025.  \n- **Key Transactions**:  \n  - Net sales of **197,455 AGN shares** across subsidiaries (IOOF/MLC) from Dec-2024 to Jul-2025.  \n  - Prior net purchases of **340,805 shares** between Jul-2024 and Mar-2025.  \n\n*No other material information identified.*",
  "usage": {
    "prompt_tokens": 1060,
    "completion_tokens": 115,
    "total_tokens": 1175,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-23T06:19:19.749081"
}